Galmed Pharmaceuticals Stock Investor Sentiment

GLMD Stock  USD 2.68  0.02  0.74%   
About 62% of Galmed Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Galmed Pharmaceuticals stock suggests that many investors are alarmed at this time. The current market sentiment, together with Galmed Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Galmed Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
over a year ago at thelincolnianonline.com         
Short Interest in Galmed Pharmaceuticals Ltd. Decreases By 9.7
news
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Earns Sell Rating from Analysts at StockNews.com
news
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Now Covered by Analysts at StockNews.com
news
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Now Covered by StockNews.com
news
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Coverage Initiated at StockNews.com
news
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Shares Pass Below 50-Day Moving Average of 0.38
news
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Now Covered by Analysts at StockNews.com
news
over a year ago at news.google.com         
Israeli med-tech cos among best and worst Nasdaq stocks - Globes
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Short Interest in Galmed Pharmaceuticals Ltd. Rises By 564.3
news
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Coverage Initiated by Analysts at StockNews.com
news
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Now Covered by Analysts at StockNews.com
news
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals Now Covered by Analysts at StockNews.com
news
over a year ago at kalkinemedia.com         
Non-Alcoholic Steatohepatitis Market Expected to Reach 21,478 Million by 2025
news
over a year ago at news.google.com         
Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Third ... - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Galmed Pharmaceuticals to Release Earnings on Tuesday
news
Far too much social signal, news, headlines, and media speculation about Galmed Pharmaceuticals that are available to investors today. That information is available publicly through Galmed media outlets and privately through word of mouth or via Galmed internal channels. However, regardless of the origin, that massive amount of Galmed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Galmed Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Galmed Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Galmed Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Galmed Pharmaceuticals alpha.

Galmed Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Galmed Stock analysis

When running Galmed Pharmaceuticals' price analysis, check to measure Galmed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galmed Pharmaceuticals is operating at the current time. Most of Galmed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Galmed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galmed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Galmed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency